DAPAGLIFLOZIN

Clinical Indication

Chronic Heart failure with reduced ejection fraction and preserved ejection fraction

Comments

In line with NICE TA679 and  NICE TA902

Guidance on Generic SGLT2i Prescribing in LLR

Date of classification

March 2021

Yellow

Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .